Levetiracetam for Persons at Risk for Alzheimer's Disease

Clinical trial NCT07477431 · RECRUITING

Trial details

NCT number: NCT07477431
Sponsor: Sunnybrook Health Sciences Centre
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hippocampal Hyperactivation Prodromal Alzheimer Disease

Start date: 2025-10-23
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.